The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their ...

The immune systems of cancer patients may play a significant role in their treatment outcomes, according to a study released ...

Yun-Hsin Liu, Research Assistant at the UCL Cancer Institute, and co-first author, said, "We wanted to build on the previous work developing ORACLE and show that it can predict survival at the ...

A groundbreaking study has revealed that the immune system plays a crucial role in determining the survival chances of cancer ...

The institute is a partnership between Cancer Research UK, Imperial College London, King's College London (KCL), the Medical Research Council, University College London (UCL) and the Wellcome Trust.

as well as an Associate Professor/Principal Clinical Research Fellow at the UCL Cancer Institute ...

UCLH consultant medical oncologist and UCL Cancer Institute clinical researcher Professor John Bridgewater said: “With the current standard of care, patients typically only live for one year ...

HIT-Meso is a clinical trial led by Consultant Clinical Oncologist, Dr Crispin Hiley and based at the UCL Cancer Institute. You can see details of the main clinical trial on the UCL website. HIT-Meso ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used ...

UCLH consultant medical oncologist and UCL Cancer Institute clinical researcher Professor John Bridgewater said: “With the current standard of care, patients typically only live for one year after ...